Severe Septic Patients with Mitochondrial DNA Haplogroup JT Show Higher Survival Rates: A Prospective, Multicenter, Observational Study
Lorente, L. ; Iceta, R. ; Martín, M.M. ; López-Gallardo, E. (Universidad de Zaragoza) ; Solé-Violán, J. ; Blanquer, J. ; Labarta, L. ; Díaz, C. ; Borreguero-León, J.M. ; Jiménez, A. (Universidad de Zaragoza) ; Montoya, J. ; Ruiz-Pesini, E. (Universidad de Zaragoza)
Resumen: Objective
In a previous cohort study (n=96), we found an association between mitochondrial (mt) DNA haplogroup JT and increased survival of severe septic patients, after controlling for age and serum lactic acid levels. The aim of this research was to increase the predictive accuracy and to control for more confounder variables in a larger cohort (n=196) of severe septic patients, to confirm whether mtDNA haplogroup JT influences short and medium-term survival in these patients.
Methods
We conducted a prospective, multicenter, observational study in six Spanish Intensive Care Units. We determined 30-day and 6-month survival and mtDNA haplogroup in this second cohort of 196 patients and in the global cohort (first and second cohorts combined) with 292 severe septic patients. Multiple logistic regression and Cox regression analyses were used to test for the association of mtDNA haplogroups JT with survival at 30-days and 6-months, controlling for age, sex, serum interleukin-6 levels and SOFA score.
Results
Logistic and Cox regression analyses showed no differences in 30-day and 6-month survival between patients with mtDNA haplogroup JT and other haplogroups in the first cohort (n=96). In the second cohort (n=196), these analyses showed a trend to higher 30-day and 6-month survival in those with haplogroup JT. In the global cohort (n=292), logistic and Cox regression analyses showed higher 30-day and 6-month survival for haplogroup JT. There were no significant differences between J and T sub-haplogroups in 30-day and 6-month survival.
Conclusions
The global cohort study (first and second cohorts combined), the largest to date reporting on mtDNA haplogroups in septic patients, confirmed that haplogroup JT patients showed increased 30-day and 6-month survival. This finding may be due to single nucleotide polymorphism defining the whole haplogroup JT and not separately for J or T sub-haplogroups.
Idioma: Inglés
DOI: 10.1371/journal.pone.0073320
Año: 2013
Publicado en: PLoS One 8, 9 (2013), e73320 [7 pp]
ISSN: 1932-6203
Factor impacto JCR: 3.534 (2013)
Categ. JCR: MULTIDISCIPLINARY SCIENCES rank: 8 / 55 = 0.145 (2013) - Q1 - T1
Financiación: info:eu-repo/grantAgreement/ES/DGA/B33
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI10-00662
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI10-01301
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI10-01572
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/I3SNS-INT-11-063
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/I3SNS-INT-12-087
Tipo y forma: Article (Published version)
Área (Departamento): Bioquímica y Biología Molecular (Departamento de Bioquímica y Biología Molecular y Celular)
You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
Exportado de SIDERAL (2017-06-12-09:14:09)
Visitas y descargas
In a previous cohort study (n=96), we found an association between mitochondrial (mt) DNA haplogroup JT and increased survival of severe septic patients, after controlling for age and serum lactic acid levels. The aim of this research was to increase the predictive accuracy and to control for more confounder variables in a larger cohort (n=196) of severe septic patients, to confirm whether mtDNA haplogroup JT influences short and medium-term survival in these patients.
Methods
We conducted a prospective, multicenter, observational study in six Spanish Intensive Care Units. We determined 30-day and 6-month survival and mtDNA haplogroup in this second cohort of 196 patients and in the global cohort (first and second cohorts combined) with 292 severe septic patients. Multiple logistic regression and Cox regression analyses were used to test for the association of mtDNA haplogroups JT with survival at 30-days and 6-months, controlling for age, sex, serum interleukin-6 levels and SOFA score.
Results
Logistic and Cox regression analyses showed no differences in 30-day and 6-month survival between patients with mtDNA haplogroup JT and other haplogroups in the first cohort (n=96). In the second cohort (n=196), these analyses showed a trend to higher 30-day and 6-month survival in those with haplogroup JT. In the global cohort (n=292), logistic and Cox regression analyses showed higher 30-day and 6-month survival for haplogroup JT. There were no significant differences between J and T sub-haplogroups in 30-day and 6-month survival.
Conclusions
The global cohort study (first and second cohorts combined), the largest to date reporting on mtDNA haplogroups in septic patients, confirmed that haplogroup JT patients showed increased 30-day and 6-month survival. This finding may be due to single nucleotide polymorphism defining the whole haplogroup JT and not separately for J or T sub-haplogroups.
Idioma: Inglés
DOI: 10.1371/journal.pone.0073320
Año: 2013
Publicado en: PLoS One 8, 9 (2013), e73320 [7 pp]
ISSN: 1932-6203
Factor impacto JCR: 3.534 (2013)
Categ. JCR: MULTIDISCIPLINARY SCIENCES rank: 8 / 55 = 0.145 (2013) - Q1 - T1
Financiación: info:eu-repo/grantAgreement/ES/DGA/B33
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI10-00662
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI10-01301
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI10-01572
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/I3SNS-INT-11-063
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/I3SNS-INT-12-087
Tipo y forma: Article (Published version)
Área (Departamento): Bioquímica y Biología Molecular (Departamento de Bioquímica y Biología Molecular y Celular)
You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. Exportado de SIDERAL (2017-06-12-09:14:09)
Permalink:
Visitas y descargas
Este artículo se encuentra en las siguientes colecciones:
Articles > Artículos por área > Bioquímica y Biología Molecular
Record created 2017-06-12, last modified 2017-06-12